Charles River Laboratories International (CRL) Operating Leases: 2019-2024
Historic Operating Leases for Charles River Laboratories International (CRL) over the last 6 years, with Dec 2024 value amounting to $483.8 million.
- Charles River Laboratories International's Operating Leases rose 2.39% to $443.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $443.2 million, marking a year-over-year increase of 2.39%. This contributed to the annual value of $483.8 million for FY2024, which is 2.03% up from last year.
- Latest data reveals that Charles River Laboratories International reported Operating Leases of $483.8 million as of FY2024, which was up 2.03% from $474.1 million recorded in FY2023.
- In the past 5 years, Charles River Laboratories International's Operating Leases registered a high of $483.8 million during FY2024, and its lowest value of $180.3 million during FY2020.
- In the last 3 years, Charles River Laboratories International's Operating Leases had a median value of $474.1 million in 2023 and averaged $464.7 million.
- Data for Charles River Laboratories International's Operating Leases shows a peak YoY spiked of 58.78% (in 2021) over the last 5 years.
- Charles River Laboratories International's Operating Leases (Yearly) stood at $180.3 million in 2020, then spiked by 58.78% to $286.2 million in 2021, then skyrocketed by 52.41% to $436.3 million in 2022, then increased by 8.68% to $474.1 million in 2023, then rose by 2.03% to $483.8 million in 2024.